See All Slides - tctmd.com

Slides

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

ELM Presentation(8)

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

Radial Artery Patency After Transradial Angiography and Intervention: The Next "Open Artery" Hypothesis?

Presenter: Zoltan Turi

October 23, 2012

Presentation TCT 2012

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Presenter: James Min

October 23, 2012

Presentation TCT 2012

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

Appropriateness Criteria: Implications for Clinical Practice

Presenter: Monica Losquadro

October 23, 2012

Presentation TCT 2012

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

Presenter: Bryan Brewster

October 23, 2012

Presentation TCT 2012

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Presenter: George Dangas

October 23, 2012

Presentation TCT 2012

Subcutaneous Defibrillators

Presenter: Gust Bardy

October 23, 2012

Presentation TCT 2012

Payment Reform: Prepare for the Changes

Presenter: Pamela Douglas

October 23, 2012

Advertisement

Slides

Background Medical and Device Therapies for Patients with VADs

ELM Presentation(8)

Radial Artery Patency After Transradial Angiography and Intervention: The Next "Open Artery" Hypothesis?

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Appropriateness Criteria: Implications for Clinical Practice

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Subcutaneous Defibrillators

Payment Reform: Prepare for the Changes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content